SVB Leerink Downgrades Inflarx NV (IFRX) to Market Perform, Following Pharma Study Fail
Tweet Send to a Friend
SVB Leerink analyst Joseph Schwartz downgraded Inflarx NV (NASDAQ: IFRX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
